Trial of Local Cystoscopic Injection of Tremelimumab Plus Systemic Durvalumab for High Risk Non-Muscle Invasive Bladder Cancer

Clinical trial NCT05120622 · WITHDRAWN

Trial details

NCT number: NCT05120622
Sponsor: University of British Columbia
Status: WITHDRAWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Bladder Cancer High-Risk Cancer Tremelimumab Durvalumab Non-muscle Invasive

Start date: 2021-09-01
Primary completion: 2022-05-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.